EUDA Health Holdings Ltd Files 6-K Report
Ticker: EUDAW · Form: 6-K · Filed: Oct 18, 2024 · CIK: 1847846
Sentiment: neutral
Topics: 6-K, corporate-filing, foreign-private-issuer
TL;DR
EUDA Health Holdings Ltd (formerly 8i Acquisition 2 Corp.) filed its 6-K report for the period ending 06/30/2024.
AI Summary
EUDA Health Holdings Ltd, formerly 8i Acquisition 2 Corp., filed a Form 6-K on October 18, 2024, reporting for the period ending June 30, 2024. The company is incorporated in D8 and its fiscal year ends on December 31. The filing indicates it is a foreign private issuer submitting its report under the 1934 Securities Exchange Act.
Why It Matters
This filing provides an update on EUDA Health Holdings Ltd's reporting status and corporate information, which is crucial for investors tracking the company's compliance and financial disclosures.
Risk Assessment
Risk Level: low — This is a routine filing providing corporate information and does not contain significant new financial or operational developments.
Key Numbers
- 001-40678 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- EUDA Health Holdings Ltd (company) — Registrant
- 8i Acquisition 2 Corp. (company) — Former company name
- 001-40678 (company) — SEC File Number
- 20241018 (date) — Filing date
- 20240630 (date) — Period of report
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of October 2024.
What was EUDA Health Holdings Ltd's former name?
EUDA Health Holdings Ltd was formerly known as 8i Acquisition 2 Corp.
When is the reported period for this filing?
The conformed period of report is 20240630 (June 30, 2024).
What is the company's principal executive office address?
The company's principal executive office is located at 1 Pemimpin Drive #12-06, One Pemimpin, Singapore 576151.
Does the company file annual reports under Form 20-F or 40-F?
The registrant indicates it files annual reports under cover of Form 20-F.
Filing Stats: 427 words · 2 min read · ~1 pages · Grade level 17.7 · Accepted 2024-10-18 09:09:04
Filing Documents
- form6-k.htm (6-K) — 23KB
- ex99-1.htm (EX-99.1) — 1737KB
- ex99-2.htm (EX-99.2) — 77KB
- 0001493152-24-041511.txt ( ) — 11207KB
- euda-20240630.xsd (EX-101.SCH) — 88KB
- euda-20240630_cal.xml (EX-101.CAL) — 111KB
- euda-20240630_def.xml (EX-101.DEF) — 344KB
- euda-20240630_lab.xml (EX-101.LAB) — 644KB
- euda-20240630_pre.xml (EX-101.PRE) — 492KB
- form6-k_htm.xml (XML) — 2255KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: October 18, 2024 EUDA Health Holdings Limited By: /s/ Wei Wen Kelvin Chen Name: Wei Wen Kelvin Chen Title: Chief Executive Officer